Evercore ISI Resumes Mirum (MIRM) at Outperform, PT $62, 'strong business with a long growth runway ahead'
Tweet Send to a Friend
(Updated - October 17, 2023 6:26 AM EDT)
Evercore ISI analyst Gavin Clark-Gartner resumes coverage on Mirum Pharamceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Evercore ISI analyst Gavin Clark-Gartner resumes coverage on Mirum Pharamceuticals (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
